These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome. Marušić Z; Buljan M; Busam KJ J Cutan Pathol; 2015 Jun; 42(6):406-12. PubMed ID: 25902915 [TBL] [Abstract][Full Text] [Related]
6. Clinical and dermoscopic features of cutaneous BAP1-inactivated melanocytic tumors: Results of a multicenter case-control study by the International Dermoscopy Society. Yélamos O; Navarrete-Dechent C; Marchetti MA; Rogers T; Apalla Z; Bahadoran P; Blázquez-Sánchez N; Busam K; Carrera C; Dusza SW; de la Fouchardière A; Ferrara G; Gerami P; Kittler H; Lallas A; Malvehy J; Millán-Cayetano JF; Nelson KC; Quan VL; Puig S; Stevens H; Thomas L; Marghoob AA J Am Acad Dermatol; 2019 Jun; 80(6):1585-1593. PubMed ID: 30244062 [TBL] [Abstract][Full Text] [Related]
7. Germline BRCA1-associated protein 1 mutation presenting as BAP1 inactivated melanocytic nevi in a child of a father with fatal paraganglioma. Watchorn RE; Calonje E; Taibjee SM Pediatr Dermatol; 2018 Sep; 35(5):e316-e318. PubMed ID: 29974497 [TBL] [Abstract][Full Text] [Related]
8. Integrated Genomic Classification of Melanocytic Tumors of the Central Nervous System Using Mutation Analysis, Copy Number Alterations, and DNA Methylation Profiling. Griewank KG; Koelsche C; van de Nes JAP; Schrimpf D; Gessi M; Möller I; Sucker A; Scolyer RA; Buckland ME; Murali R; Pietsch T; von Deimling A; Schadendorf D Clin Cancer Res; 2018 Sep; 24(18):4494-4504. PubMed ID: 29891723 [No Abstract] [Full Text] [Related]
9. Melanomas Associated With Blue Nevi or Mimicking Cellular Blue Nevi: Clinical, Pathologic, and Molecular Study of 11 Cases Displaying a High Frequency of GNA11 Mutations, BAP1 Expression Loss, and a Predilection for the Scalp. Costa S; Byrne M; Pissaloux D; Haddad V; Paindavoine S; Thomas L; Aubin F; Lesimple T; Grange F; Bonniaud B; Mortier L; Mateus C; Dreno B; Balme B; Vergier B; de la Fouchardiere A Am J Surg Pathol; 2016 Mar; 40(3):368-77. PubMed ID: 26645730 [TBL] [Abstract][Full Text] [Related]
10. Difficult to Diagnose Cutaneous Melanoma in a Patient with BAP1 Tumor Predisposition Syndrome. Silva-Clavería F; Álvarez-Muñoz A; Ferrándiz L; Fernández-Orland A; Conde-Martin AF; Moreno-Ramírez D; Ríos-Martín JJ Int J Surg Pathol; 2023 Oct; 31(7):1398-1402. PubMed ID: 36803128 [TBL] [Abstract][Full Text] [Related]
11. Multiple epithelioid Spitz nevi or tumors with loss of BAP1 expression: a clue to a hereditary tumor syndrome. Busam KJ; Wanna M; Wiesner T JAMA Dermatol; 2013 Mar; 149(3):335-9. PubMed ID: 23552620 [TBL] [Abstract][Full Text] [Related]
12. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy. Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384 [TBL] [Abstract][Full Text] [Related]
13. SF3B1 and BAP1 mutations in blue nevus-like melanoma. Griewank KG; Müller H; Jackett LA; Emberger M; Möller I; van de Nes JA; Zimmer L; Livingstone E; Wiesner T; Scholz SL; Cosgarea I; Sucker A; Schimming T; Hillen U; Schilling B; Paschen A; Reis H; Mentzel T; Kutzner H; Rütten A; Murali R; Scolyer RA; Schadendorf D Mod Pathol; 2017 Jul; 30(7):928-939. PubMed ID: 28409567 [TBL] [Abstract][Full Text] [Related]
15. A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression. Wiesner T; Murali R; Fried I; Cerroni L; Busam K; Kutzner H; Bastian BC Am J Surg Pathol; 2012 Jun; 36(6):818-30. PubMed ID: 22367297 [TBL] [Abstract][Full Text] [Related]
16. Histologically Diverse BAP1-Deficient Melanocytic Tumors in a Patient With BAP1 Tumor Predisposition Syndrome. Louw A; Creaney J; Thomas A; Van Vliet C; Harvey NT; Wood BA; Mesbah Ardakani N Am J Dermatopathol; 2020 Nov; 42(11):872-875. PubMed ID: 32649346 [TBL] [Abstract][Full Text] [Related]
17. Occurrence of BAP1 germline mutations in cutaneous melanocytic tumors with loss of BAP1-expression: A pilot study. Cabaret O; Perron E; Bressac-de Paillerets B; Soufir N; de la Fouchardière A Genes Chromosomes Cancer; 2017 Sep; 56(9):691-694. PubMed ID: 28560743 [TBL] [Abstract][Full Text] [Related]
18. BAP1-inactivated melanocytic tumors show prominent centrosome amplification and associated loss of primary cilia. Ye J; Sheahon KM; LeBoit PE; McCalmont TH; Lang UE J Cutan Pathol; 2021 Nov; 48(11):1353-1360. PubMed ID: 34085298 [TBL] [Abstract][Full Text] [Related]
19. Genotypic and Phenotypic Features of BAP1 Cancer Syndrome: A Report of 8 New Families and Review of Cases in the Literature. Haugh AM; Njauw CN; Bubley JA; Verzì AE; Zhang B; Kudalkar E; VandenBoom T; Walton K; Swick BL; Kumar R; Rana HQ; Cochrane S; McCormick SR; Shea CR; Tsao H; Gerami P JAMA Dermatol; 2017 Oct; 153(10):999-1006. PubMed ID: 28793149 [TBL] [Abstract][Full Text] [Related]
20. Multiple Cutaneous Melanomas and Clinically Atypical Moles in a Patient With a Novel Germline BAP1 Mutation. Gerami P; Yélamos O; Lee CY; Obregon R; Yazdan P; Sholl LM; Guitart GE; Njauw CN; Tsao H JAMA Dermatol; 2015 Nov; 151(11):1235-9. PubMed ID: 26154183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]